CN102552619A - Medicine for treating tumor and preparation method thereof - Google Patents
Medicine for treating tumor and preparation method thereof Download PDFInfo
- Publication number
- CN102552619A CN102552619A CN2012100123303A CN201210012330A CN102552619A CN 102552619 A CN102552619 A CN 102552619A CN 2012100123303 A CN2012100123303 A CN 2012100123303A CN 201210012330 A CN201210012330 A CN 201210012330A CN 102552619 A CN102552619 A CN 102552619A
- Authority
- CN
- China
- Prior art keywords
- parts
- medicine
- tumor
- treatment
- crude drug
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 246
- 206010028980 Neoplasm Diseases 0.000 title claims abstract description 179
- 229940079593 drug Drugs 0.000 title claims abstract description 120
- 238000002360 preparation method Methods 0.000 title abstract description 18
- 239000000843 powder Substances 0.000 claims abstract description 61
- 240000002853 Nelumbo nucifera Species 0.000 claims abstract description 49
- 235000006508 Nelumbo nucifera Nutrition 0.000 claims abstract description 49
- 235000006510 Nelumbo pentapetala Nutrition 0.000 claims abstract description 49
- 239000002775 capsule Substances 0.000 claims abstract description 35
- 235000011837 pasties Nutrition 0.000 claims abstract description 11
- 238000002156 mixing Methods 0.000 claims abstract description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 8
- 239000007788 liquid Substances 0.000 claims abstract description 5
- 238000011282 treatment Methods 0.000 claims description 134
- 241000222336 Ganoderma Species 0.000 claims description 59
- 244000153234 Hibiscus abelmoschus Species 0.000 claims description 51
- 241000283956 Manis Species 0.000 claims description 49
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 43
- 210000000952 spleen Anatomy 0.000 claims description 26
- 239000000203 mixture Substances 0.000 claims description 13
- 238000000034 method Methods 0.000 claims description 12
- 241000628997 Flos Species 0.000 claims description 8
- 241001465754 Metazoa Species 0.000 claims description 8
- 238000005303 weighing Methods 0.000 claims description 7
- 239000002552 dosage form Substances 0.000 claims description 3
- 238000000227 grinding Methods 0.000 claims description 3
- 230000008569 process Effects 0.000 claims description 3
- 210000004369 blood Anatomy 0.000 abstract description 58
- 239000008280 blood Substances 0.000 abstract description 58
- 230000000694 effects Effects 0.000 abstract description 56
- 230000001737 promoting effect Effects 0.000 abstract description 36
- 231100000614 poison Toxicity 0.000 abstract description 24
- 230000017531 blood circulation Effects 0.000 abstract description 21
- 201000011510 cancer Diseases 0.000 abstract description 15
- 230000006870 function Effects 0.000 abstract description 11
- 230000036039 immunity Effects 0.000 abstract description 8
- 230000001105 regulatory effect Effects 0.000 abstract description 8
- 239000002574 poison Substances 0.000 abstract description 7
- 230000002147 killing effect Effects 0.000 abstract description 4
- 230000008901 benefit Effects 0.000 abstract description 3
- 238000009835 boiling Methods 0.000 abstract description 2
- 230000002401 inhibitory effect Effects 0.000 abstract description 2
- 230000001502 supplementing effect Effects 0.000 abstract description 2
- 241000402754 Erythranthe moschata Species 0.000 abstract 2
- 241000282806 Rhinoceros Species 0.000 abstract 2
- 241000382455 Angelica sinensis Species 0.000 abstract 1
- 244000075634 Cyperus rotundus Species 0.000 abstract 1
- 235000016854 Cyperus rotundus Nutrition 0.000 abstract 1
- 240000008397 Ganoderma lucidum Species 0.000 abstract 1
- 235000001637 Ganoderma lucidum Nutrition 0.000 abstract 1
- 241000244365 Ligusticum sinense Species 0.000 abstract 1
- 244000170916 Paeonia officinalis Species 0.000 abstract 1
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract 1
- 241000283966 Pholidota <mammal> Species 0.000 abstract 1
- 244000197580 Poria cocos Species 0.000 abstract 1
- 235000008599 Poria cocos Nutrition 0.000 abstract 1
- 238000003801 milling Methods 0.000 abstract 1
- 210000004185 liver Anatomy 0.000 description 35
- 208000002193 Pain Diseases 0.000 description 29
- 201000010099 disease Diseases 0.000 description 21
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 21
- 230000001225 therapeutic effect Effects 0.000 description 18
- 210000002216 heart Anatomy 0.000 description 16
- 235000012054 meals Nutrition 0.000 description 16
- 210000002784 stomach Anatomy 0.000 description 13
- 230000004087 circulation Effects 0.000 description 12
- 230000003203 everyday effect Effects 0.000 description 12
- 210000003734 kidney Anatomy 0.000 description 12
- 238000001959 radiotherapy Methods 0.000 description 11
- 206010019233 Headaches Diseases 0.000 description 10
- 235000009508 confectionery Nutrition 0.000 description 10
- 230000008961 swelling Effects 0.000 description 10
- 208000024891 symptom Diseases 0.000 description 10
- 206010007247 Carbuncle Diseases 0.000 description 9
- 206010042674 Swelling Diseases 0.000 description 9
- 210000004027 cell Anatomy 0.000 description 9
- 230000007812 deficiency Effects 0.000 description 9
- 239000007789 gas Substances 0.000 description 9
- 231100000869 headache Toxicity 0.000 description 9
- 230000007096 poisonous effect Effects 0.000 description 9
- 239000003440 toxic substance Substances 0.000 description 9
- 208000032612 Glial tumor Diseases 0.000 description 8
- 206010018338 Glioma Diseases 0.000 description 8
- 206010062717 Increased upper airway secretion Diseases 0.000 description 8
- 238000002512 chemotherapy Methods 0.000 description 8
- 230000001717 pathogenic effect Effects 0.000 description 8
- 208000026435 phlegm Diseases 0.000 description 8
- 239000002994 raw material Substances 0.000 description 8
- 208000029312 Muscular tumor Diseases 0.000 description 7
- 230000002159 abnormal effect Effects 0.000 description 7
- 208000002173 dizziness Diseases 0.000 description 7
- 210000004072 lung Anatomy 0.000 description 7
- 206010010774 Constipation Diseases 0.000 description 6
- 230000006378 damage Effects 0.000 description 6
- 208000014674 injury Diseases 0.000 description 6
- 244000052769 pathogen Species 0.000 description 6
- 238000011084 recovery Methods 0.000 description 6
- 206010011224 Cough Diseases 0.000 description 5
- 208000033809 Suppuration Diseases 0.000 description 5
- 206010046798 Uterine leiomyoma Diseases 0.000 description 5
- 208000019790 abdominal distention Diseases 0.000 description 5
- 230000001093 anti-cancer Effects 0.000 description 5
- 230000036528 appetite Effects 0.000 description 5
- 235000019789 appetite Nutrition 0.000 description 5
- 230000001174 ascending effect Effects 0.000 description 5
- 230000001276 controlling effect Effects 0.000 description 5
- 230000005311 nuclear magnetism Effects 0.000 description 5
- 210000000582 semen Anatomy 0.000 description 5
- 230000008736 traumatic injury Effects 0.000 description 5
- 210000001835 viscera Anatomy 0.000 description 5
- 206010010904 Convulsion Diseases 0.000 description 4
- 208000002699 Digestive System Neoplasms Diseases 0.000 description 4
- 208000000059 Dyspnea Diseases 0.000 description 4
- 206010013975 Dyspnoeas Diseases 0.000 description 4
- 208000004880 Polyuria Diseases 0.000 description 4
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 4
- 230000002490 cerebral effect Effects 0.000 description 4
- 239000000812 cholinergic antagonist Substances 0.000 description 4
- 230000036461 convulsion Effects 0.000 description 4
- 230000035619 diuresis Effects 0.000 description 4
- 210000003238 esophagus Anatomy 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 206010022437 insomnia Diseases 0.000 description 4
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 4
- 230000005855 radiation Effects 0.000 description 4
- 201000000849 skin cancer Diseases 0.000 description 4
- 201000008261 skin carcinoma Diseases 0.000 description 4
- 230000002048 spasmolytic effect Effects 0.000 description 4
- 231100000419 toxicity Toxicity 0.000 description 4
- 230000001988 toxicity Effects 0.000 description 4
- 206010000087 Abdominal pain upper Diseases 0.000 description 3
- 201000000736 Amenorrhea Diseases 0.000 description 3
- 206010001928 Amenorrhoea Diseases 0.000 description 3
- 208000006820 Arthralgia Diseases 0.000 description 3
- 208000017897 Carcinoma of esophagus Diseases 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 208000005171 Dysmenorrhea Diseases 0.000 description 3
- 206010013935 Dysmenorrhoea Diseases 0.000 description 3
- 206010017553 Furuncle Diseases 0.000 description 3
- 208000008454 Hyperhidrosis Diseases 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 206010030155 Oesophageal carcinoma Diseases 0.000 description 3
- 208000005718 Stomach Neoplasms Diseases 0.000 description 3
- 208000006011 Stroke Diseases 0.000 description 3
- 238000009825 accumulation Methods 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 231100000540 amenorrhea Toxicity 0.000 description 3
- 208000007502 anemia Diseases 0.000 description 3
- 206010003549 asthenia Diseases 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 238000002651 drug therapy Methods 0.000 description 3
- 208000001848 dysentery Diseases 0.000 description 3
- 201000005619 esophageal carcinoma Diseases 0.000 description 3
- 239000003205 fragrance Substances 0.000 description 3
- 206010017758 gastric cancer Diseases 0.000 description 3
- 230000023597 hemostasis Effects 0.000 description 3
- 238000007689 inspection Methods 0.000 description 3
- 210000000265 leukocyte Anatomy 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 244000045947 parasite Species 0.000 description 3
- 150000003254 radicals Chemical class 0.000 description 3
- 201000011549 stomach cancer Diseases 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 206010042772 syncope Diseases 0.000 description 3
- 210000004881 tumor cell Anatomy 0.000 description 3
- 241000255791 Bombyx Species 0.000 description 2
- 206010008190 Cerebrovascular accident Diseases 0.000 description 2
- 206010010071 Coma Diseases 0.000 description 2
- 201000000297 Erysipelas Diseases 0.000 description 2
- 208000019255 Menstrual disease Diseases 0.000 description 2
- 241001057584 Myrrha Species 0.000 description 2
- 206010033557 Palpitations Diseases 0.000 description 2
- 206010036790 Productive cough Diseases 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- 208000025747 Rheumatic disease Diseases 0.000 description 2
- 208000004078 Snake Bites Diseases 0.000 description 2
- 208000005392 Spasm Diseases 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 description 2
- 208000001780 epistaxis Diseases 0.000 description 2
- 239000003172 expectorant agent Substances 0.000 description 2
- 230000003419 expectorant effect Effects 0.000 description 2
- 208000024756 faint Diseases 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 208000035861 hematochezia Diseases 0.000 description 2
- 230000002607 hemopoietic effect Effects 0.000 description 2
- 210000003026 hypopharynx Anatomy 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 238000002649 immunization Methods 0.000 description 2
- 230000003053 immunization Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- 201000007227 lymph node tuberculosis Diseases 0.000 description 2
- 206010025482 malaise Diseases 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 230000002175 menstrual effect Effects 0.000 description 2
- 230000005906 menstruation Effects 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 210000000496 pancreas Anatomy 0.000 description 2
- OXNIZHLAWKMVMX-UHFFFAOYSA-N picric acid Chemical compound OC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-N 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 230000002685 pulmonary effect Effects 0.000 description 2
- 230000001047 pyretic effect Effects 0.000 description 2
- 230000002040 relaxant effect Effects 0.000 description 2
- 230000000552 rheumatic effect Effects 0.000 description 2
- 230000000630 rising effect Effects 0.000 description 2
- 230000035943 smell Effects 0.000 description 2
- 235000015096 spirit Nutrition 0.000 description 2
- 208000024794 sputum Diseases 0.000 description 2
- 210000003802 sputum Anatomy 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 239000004575 stone Substances 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- 230000035900 sweating Effects 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 230000017423 tissue regeneration Effects 0.000 description 2
- 230000000699 topical effect Effects 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 210000003932 urinary bladder Anatomy 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- FFRBMBIXVSCUFS-UHFFFAOYSA-N 2,4-dinitro-1-naphthol Chemical compound C1=CC=C2C(O)=C([N+]([O-])=O)C=C([N+]([O-])=O)C2=C1 FFRBMBIXVSCUFS-UHFFFAOYSA-N 0.000 description 1
- 241001290610 Abildgaardia Species 0.000 description 1
- 244000235603 Acacia catechu Species 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 241000213006 Angelica dahurica Species 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 235000006226 Areca catechu Nutrition 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 208000037260 Atherosclerotic Plaque Diseases 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 208000003014 Bites and Stings Diseases 0.000 description 1
- 241000717739 Boswellia sacra Species 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 241000660877 Coridius Species 0.000 description 1
- 241000218176 Corydalis Species 0.000 description 1
- 208000028399 Critical Illness Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 101100136092 Drosophila melanogaster peng gene Proteins 0.000 description 1
- 201000009273 Endometriosis Diseases 0.000 description 1
- 241000201295 Euphrasia Species 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 206010055690 Foetal death Diseases 0.000 description 1
- 239000004863 Frankincense Substances 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 208000018779 Globus Sensation Diseases 0.000 description 1
- 102000004366 Glucosidases Human genes 0.000 description 1
- 108010056771 Glucosidases Proteins 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 206010019637 Hepatic atrophy Diseases 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000019468 Iatrogenic Disease Diseases 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 208000005016 Intestinal Neoplasms Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 206010027336 Menstruation delayed Diseases 0.000 description 1
- 206010027457 Metastases to liver Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 208000002454 Nasopharyngeal Carcinoma Diseases 0.000 description 1
- 206010061306 Nasopharyngeal cancer Diseases 0.000 description 1
- 208000012902 Nervous system disease Diseases 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 241001597008 Nomeidae Species 0.000 description 1
- 241000590428 Panacea Species 0.000 description 1
- HCOLPNRPCMFHOH-UHFFFAOYSA-N Prodigiosin Natural products CCCCCC1C=C(C=C/2N=C(C=C2OC)c3ccc[nH]3)N=C1C HCOLPNRPCMFHOH-UHFFFAOYSA-N 0.000 description 1
- 201000002154 Pterygium Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 208000015634 Rectal Neoplasms Diseases 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 108010017842 Telomerase Proteins 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 208000024770 Thyroid neoplasm Diseases 0.000 description 1
- 208000003443 Unconsciousness Diseases 0.000 description 1
- 241001520094 Uroctea Species 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000000146 antalgic effect Effects 0.000 description 1
- 230000000507 anthelmentic effect Effects 0.000 description 1
- 230000001088 anti-asthma Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000000118 anti-neoplastic effect Effects 0.000 description 1
- 230000001741 anti-phlogistic effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000000729 antidote Substances 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 229910052788 barium Inorganic materials 0.000 description 1
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000019636 bitter flavor Nutrition 0.000 description 1
- 208000002352 blister Diseases 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 229910021538 borax Inorganic materials 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 230000009172 bursting Effects 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 210000002318 cardia Anatomy 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 230000005465 channeling Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 208000020832 chronic kidney disease Diseases 0.000 description 1
- 208000022831 chronic renal failure syndrome Diseases 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 238000004581 coalescence Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 208000012839 conversion disease Diseases 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 208000010643 digestive system disease Diseases 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 208000000718 duodenal ulcer Diseases 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 210000003038 endothelium Anatomy 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 206010016766 flatulence Diseases 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 239000010135 fructus aurantii immaturus Substances 0.000 description 1
- 230000005714 functional activity Effects 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 201000004637 gastric cardia carcinoma Diseases 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 230000007160 gastrointestinal dysfunction Effects 0.000 description 1
- 238000002575 gastroscopy Methods 0.000 description 1
- 230000002984 haematinic effect Effects 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 210000003701 histiocyte Anatomy 0.000 description 1
- 230000037315 hyperhidrosis Effects 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 208000030603 inherited susceptibility to asthma Diseases 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 201000002313 intestinal cancer Diseases 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 230000006651 lactation Effects 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 238000007449 liver function test Methods 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- 230000005980 lung dysfunction Effects 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 208000022766 lymph node neoplasm Diseases 0.000 description 1
- 201000003265 lymphadenitis Diseases 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 210000004914 menses Anatomy 0.000 description 1
- 230000001394 metastastic effect Effects 0.000 description 1
- 206010061289 metastatic neoplasm Diseases 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 201000011216 nasopharynx carcinoma Diseases 0.000 description 1
- 210000000822 natural killer cell Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 208000025661 ovarian cyst Diseases 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 230000032696 parturition Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- TWFGRJUTAULJPZ-USZBIXTISA-N prodigiosin Chemical compound N1=C(C)C(CCCCC)=C\C1=C/C1=NC(C=2[N]C=CC=2)=C[C]1OC TWFGRJUTAULJPZ-USZBIXTISA-N 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 208000005069 pulmonary fibrosis Diseases 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 206010038038 rectal cancer Diseases 0.000 description 1
- 201000001275 rectum cancer Diseases 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 238000002271 resection Methods 0.000 description 1
- 230000004202 respiratory function Effects 0.000 description 1
- 208000023504 respiratory system disease Diseases 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 239000009286 sanguis draxonis Substances 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 239000004328 sodium tetraborate Substances 0.000 description 1
- 235000010339 sodium tetraborate Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 208000013076 thyroid tumor Diseases 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a medicine for treating a tumor and a preparation method thereof. The medicine for treating the tumor is mainly prepared from the following raw medicines in parts by weight: 200-250 parts of prepared pangolin, 180-250 parts of Poria cocos, 80-100 parts of Ligusticum chuanxiong, 100-150 parts of white paeony root, 60-120 parts of Angelica sinensis, 10-12 parts of toad cake, 3-5 parts of rhinoceros horn, 3-5 parts of musk, 180-220 parts of ganoderma lucidum spore powder, 30-40 parts of agilawood, 80-120 parts of Cyperus rotundus and 2000-2500 parts of lotus leaf dew. The preparation method of the medicine comprises the following steps of: adding the toad cake, the rhinoceros horn and the musk into the lotus leaf dew and mixing, milling and airing to obtain an aired medicine; and then, mixing the other raw medicines and adding water; boiling, and mixing and concentrating the boiled medicine liquid to a pasty medicine; and finally, adding the pasty medicine into the aired medicine, mixing and airing, and adding the medicine into a capsule. The medicine disclosed by the invention has the functions of supplementing qi and blood, regulating yin and yang, promoting blood circulation and removing blood stasis, combating poison with poison, improving the immunity of an organism, and killing cancer cells and inhibiting the cancer cells from being reproduced. By utilizing the medicine disclosed by the invention to treat the various tumors, the treating effect is obvious and the total effective rate is more than 90%; and the medicine has the advantages of small side effects and low cost.
Description
Technical field
The present invention relates to a kind of Chinese medicine composition, particularly relate to a kind of medicine of treating tumor and preparation method thereof.
Background technology
Tumor is that the lump or the particularity pathological changes that form paraplasm appears and in the body local histiocyte, and it can be divided into benign tumor and malignant tumor; Tumor disease is puzzled always these years medical circle and unsolved a great problem, has every year millions of people dead because of tumor disease, occupies the anteposition because of the disease death number, and it seriously affects human life and health and development and national economy.
At present, doctor trained in Western medicine is adopting chemotherapy, radiotherapy and three kinds of methods of operation aspect the treatment tumor usually, wherein; Operative treatment is the means of topical therapeutic, and postoperative is prone to recurrence, and operation is difficult for the radical cure tumor; And the side effect of radiation and chemotherapy is very big; Can cause serious iatrogenic disease and sequela, even can cause the depletion of internal organs that its difference mainly is with harm:
One, chemotherapy is one of method of systemic treatment tumor, and destruction and immunologic function that side effect mainly contains the whole body hemopoietic system reduce, and also can cause the infringement of internal organs such as heart, digestive function and nerve, so the side effect of chemotherapy is very big;
Two, radiotherapy is the method for topical therapeutic tumor, and radiotherapy can do great damage to local normal structure, or even irreversible destruction; Make the internal organs loss of function; Can cause liver cirrhosis, hepatic atrophy like liver radiotherapy, pulmonary's radiotherapy can cause pulmonary fibrosis, thereby causes pulmonary dysfunction; Modal have sputum discharge difficulty and respiratory function forfeiture and cause dyspnea, a series of concurrent diseases such as sputum deposits, pulmonary infection in lung.Can cause damage to heart if radiotherapy involves heart, cause cardiac dysfunction,, can make these internal organs losses of function if involve hollow organs such as stomach, intestinal.In a word, the side effect of chemotherapy and radiation is big, needs strictness, reasonably selects indication.So chemotherapy and radiation not too is fit to tumor treatment, in order to avoid cause unnecessary medical consequences.
At present; Adopt the medicine of Chinese traditional treatment tumour many; For example: 1, application number is " 200410018190.6 "; Denomination of invention is the patent of " a kind of Chinese medicine preparation of treating tumour ", and the medicine of this disclosure of the Invention has attacks, the eliminating mass broken stasis of blood wet by phlegm and retained fluid water, sharp gas slit capable stagnant, promoting blood circulation and removing blood stasis, the dispersing swelling and dissipating binds of appetizing in phlegm, the temperature, vein relaxing, clearing heat and detoxicating effect.But effect and obvious inadequately in oncotherapy, and side effect is arranged, easy recurrence of long duration, the radical cure effect is undesirable.2, application number is " 200410058013.0 "; Denomination of invention is the patent of " a kind of antitumor medicine composition ", and the disclosed pharmaceutical composition of this patent mainly is made up of crude drug such as Squama Manis, Pulvis Fumi Carbonisatus, triangular, Rhizoma Curcumae, Semen Armeniacae Amarum, Fructus Mume, Endothelium Corneum Gigeriae Galli, Sanguis Draxonis, Radix Sophorae Tonkinensis, Borax, Caulis Akebiae, Radix Et Rhizoma Rhei, Fructus Aurantii Immaturus, Semen Persicae, Semen Eutyales, Semen sojae atricolor, Olibanum, Myrrha, Semen phaseoli radiati, catechu, Os Sepiae, Lignum Aquilariae Resinatum, Rhizoma Corydalis, the Radix Aucklandiae, Cinnabaris, Pumex, Semen Sinapis Albae and Aspongopuss.Though this medicine has heat-clearing and toxic substances removing, hard masses softening and resolving, antineoplastic action, effect is remarkable inadequately in treatment lymphadenitis, lymphoid tuberculosis, lymph tumor, nasopharyngeal carcinoma, rectal cancer, esophageal carcinoma, and side effect is arranged.3, application number is " 200410035579.1 ", and denomination of invention is the patent of invention of " lumor eliminating powder ", and the disclosed drug main of this patent will be made up of Uroctea compatilis Koch., Bombyx Batryticatus, Bombyx bombycis, Vermilion, Fructus Jujubae, Aranea, Radix Angelicae Sinensis, Herba Violae, Myrrha etc.This medicine can be used for treating cyclomastopathy, mastitis, breast tumor, skin infection, thyroid tumor, lymph node tumor etc., but therapeutic effect and not obvious, and be prone to the recurrence symptom.
In order to solve this difficult problem of tumor; People are constantly exploring and are studying; Seek the pathogenic factor of tumor, sum up the scheme of treatment and prophylaxis of tumours, the active drug of development treatment tumor; And obtained certain therapeutic effect clinically, for mankind's prevention and treatment tumor have been made huge contribution.However, the therapeutic effect of existing Chinese medicine preparation still can not be satisfactory.
Summary of the invention
The technical problem that the present invention will solve provides a kind of medicine of treating tumor and preparation method thereof.Utilize the various tumors of Drug therapy of the present invention, its therapeutic effect is remarkable, and total effective rate reaches more than 90%, and side effect is little, and cost is low.
In order to address the above problem, the technical scheme that the present invention adopts is:
The present invention provides a kind of medicine of treating tumor, representes with weight portion, and the drug main of said treatment tumor will be by 200～250 parts of crude drug Squama Manis preparatas, 180～250 parts in Poria; 80～100 parts of Rhizoma Chuanxiongs, 100～150 parts of the Radix Paeoniae Albas, 60～120 parts of Radix Angelicae Sinensis; 10～12 parts of Venenum Bufoniss, 3～5 parts of Cornu rhinocerotis, 3～5 parts in Moschus; 180～220 parts of Ganoderma spore powders, 30～40 parts of Lignum Aquilariae Resinatum, 80～120 parts of Rhizoma Cyperi and lotus leaf drink are processed for 2000～2500 parts.The medicine of the treatment tumor that this crude drug is formed can effectively be treated various tumors.
A kind of medicine of treating tumor is represented with weight portion, and the drug main of said treatment tumor will be by 200～250 parts of crude drug Squama Manis preparatas, 180～250 parts in Poria; 80～100 parts of Rhizoma Chuanxiongs, 100～150 parts of the Radix Paeoniae Albas, 60～120 parts of Radix Angelicae Sinensis, 10～12 parts of Venenum Bufoniss; 3～5 parts of Cornu rhinocerotis, 3～5 parts in Moschus, 180～220 parts of Ganoderma spore powders, 30～40 parts of Lignum Aquilariae Resinatum; 80～120 parts of Rhizoma Cyperi, 60～100 parts of Herba Solani Nigris, 30～50 parts of xyloid stem of Flos Helianthi and lotus leaf drink are processed for 2000～2500 parts.The medicine of the treatment tumor that this crude drug is formed is mainly used in the treatment cerebroma.
A kind of medicine of treating tumor is represented with weight portion, and the drug main of said treatment tumor will be by 200～250 parts of crude drug Squama Manis preparatas, 180～250 parts in Poria; 80～100 parts of Rhizoma Chuanxiongs, 100～150 parts of the Radix Paeoniae Albas, 60～120 parts of Radix Angelicae Sinensis, 10～12 parts of Venenum Bufoniss; 3～5 parts of Cornu rhinocerotis, 3～5 parts in Moschus, 180～220 parts of Ganoderma spore powders; 30～40 parts of Lignum Aquilariae Resinatum, 80～120 parts of Rhizoma Cyperi, 80～120 parts of Herba Scutellariae Barbataes and lotus leaf drink are processed for 2000～2500 parts.The medicine of the treatment tumor that this crude drug is formed is mainly used in digestive system tumors such as treatment liver, stomach, esophagus.
A kind of medicine of treating tumor is represented with weight portion, and the drug main of said treatment tumor will be by 200～250 parts of crude drug Squama Manis preparatas, 180～250 parts in Poria; 80～100 parts of Rhizoma Chuanxiongs, 100～150 parts of the Radix Paeoniae Albas, 60～120 parts of Radix Angelicae Sinensis, 10～12 parts of Venenum Bufoniss; 3～5 parts of Cornu rhinocerotis, 3～5 parts in Moschus, 180～220 parts of Ganoderma spore powders; 30～40 parts of Lignum Aquilariae Resinatum, 80～120 parts of Rhizoma Cyperi, 100～150 parts of JIANZHONGXIAOs and lotus leaf drink are processed for 2000～2500 parts.The medicine of the treatment tumor that this crude drug is formed is mainly used in treatment hysteromyoma, ovarian cyst tumor.
A kind of medicine of treating tumor is represented with weight portion, and the drug main of said treatment tumor will be by 200～250 parts of crude drug Squama Manis preparatas, 180～250 parts in Poria; 80～100 parts of Rhizoma Chuanxiongs, 100～150 parts of the Radix Paeoniae Albas, 60～120 parts of Radix Angelicae Sinensis, 10～12 parts of Venenum Bufoniss; 3～5 parts of Cornu rhinocerotis, 3～5 parts in Moschus, 180～220 parts of Ganoderma spore powders; 30～40 parts of Lignum Aquilariae Resinatum, 80～120 parts of Rhizoma Cyperi, 3 of animal spleen and lotus leaf drink are processed for 2000～2500 parts.The medicine of the treatment tumor that this crude drug is formed is mainly used in the treatment skin carcinoma.
According to the medicine of above-mentioned each described treatment tumor, the dosage form of the medicine of said treatment tumor is a capsule.
Medicine according to above-mentioned treatment tumor is characterized in that, said capsular method for preparing is:
A, at first the crude drug proportioning ratio according to above-mentioned each described medicine for treating tumor thing takes by weighing various crude drug;
B, the crude drug Venenum Bufonis that takes by weighing, Cornu rhinocerotis and Moschus added in the lotus leaf drink carry out mixed grinding, grind and process emulsus, add the crude drug Ganoderma spore powder again and carry out air-dryly, it is for use to obtain air-dry medicine after air-dry;
C, will add entry and decoct except that Venenum Bufonis, Cornu rhinocerotis, Moschus, Ganoderma spore powder and other crude drug the lotus leaf drink mix; Decoct repeatedly three times; Each 7～9h that decocts, the addition of water decocts respectively resulting medicinal liquids mixing for add 3～6 times of the crude drug gross weight with three times when decocting at every turn; Be concentrated into pasty state after the mixing, obtain pasty medicament;
D, step c gained pasty medicament is added in the step b air-dry medicine for use, mix homogeneously, air-dry incapsulates the capsule of the tumor that obtains medical treatment after air-dry.
According to the medicine of above-mentioned treatment tumor, capsular specification described in the steps d is every 0.4g.
The present invention treats the capsular instructions of taking of tumor: ante cibum or one after each meal, every day 3 times, each 5.
The pharmacological action of the various crude drug of the present invention:
Squama Manis: cold nature, salty in the mouth, go into liver, stomach two warps.Effect cures mainly: 1, collateral dredging is searched wind: this moral character is apt to away scurry, and collateral dredging is searched wind, expelling wind and dampness, and through sick institute, with the joint insensitive impediment that disappears, stiff distortion.2, the eliminating carbuncle pus of bursting: these article circulation of qi promoting is invigorated blood circulation, dysmenorrhea dissipating blood stasis, and draw the article of heat clearing away, through sick institute, the person that do not become pus disappears and looses it, the person that become pus, burst and thoroughly it.Pus of carbuncle will become the not machine of one-tenth, and that uses is the most suitable.3, active stimulating the menstrual flow: these article can the dispelling the stagnated QI promoting the circulation of blood, can walk to scurry row again and loose, and the gas clots absorbing is opened, and menses are descending.4, dredging collateral for promoting lactation.5, xiaozheng the plot: This product salty cold, both Endometriosis, but also meridians, power lines designed to go channeling scattered, cited drugs directly to patients, and therefore eliminate disease of the plot, relieves congestion purposes.
Squama Manis preparata: get the Squama Manis sheet of choosing clean, size is separately put sand or Pulvis Talci in addition and is fried in the pot to easily, adds the Squama Manis sheet, fries to heaving when being golden yellow, takes out, and sieve shakeout or Pulvis Talci cool.
Poria: property is flat, and sweet in the mouth, light is gone into the heart, spleen, lung, bladder, three warmers, stomach the six channels.Effect cures mainly: 1, eliminating dampness and diuresis: these article diuretic and not feeling frustrated, the property of medicine is gentle, is the promoting diuresis to eliminate damp pathogen key medicine.Availablely control dysuria, edema, quench one's thirst, card such as stranguria with turbid discharge.2, invigorating the spleen and regulating the stomach: the spleen invigorating of these article ability is used for the weak card of insufficiency of the spleen stomach, the available lack of appetite of controlling, loose stool, phlegm retention cough with dyspnea, the dizzy card that waits.3, mind tranquilizing and the heart calming: these article are sweet light, go into the heart, spleen, kidney channel.Can be used for deficiency of both the heart and spleen, all cards of the irritability of disarmony between the heart and kidney.4, strong lean marrow: the tonification of the sweet ability of these article, specially go into spleen channel.Invigorating the spleen and replenishing QI, the secret vital essence of spleen invigorating, insufficiency of the spleen must the benefit, essence is closed to such an extent that solid seminal emission can end.
Rhizoma Chuanxiong: warm in nature, acrid in the mouth, hardship; Go into liver, gallbladder, bladder, tri-jiao channel.Effect cures mainly: 1, activating QI to alleviate the depression: these article suffering and gas is fragrant, and benefaction is loose, the cloudy Liver Channel of going into to faint, soothing the liver strongly fragrant, promoting the circulation of QI to relieve pain are usually used in distending pain in the chest and hypochondrium, cards such as gastral cavilty distending pain.2, dispeiling pathogenic wind and removing dampness: these article suffering can be manageed it diffusing, and fragrance is bitter dry, and expelling wind and cold and dampness often can be used for cards such as anemofrigid cold, anemofrigid-damp arthralgia, headche due to wind-cold.3, promoting blood circulation and stopping pain: these article are gas medicine in the blood, and merit is arrogated to oneself promoting flow of QI and blood, antalgic.Often can be used for cards such as puerperal blood faints, puerperal abdonimal pain, blood stasis amenorrhea.4, detumescence and apocenosis: these article promoting blood circulation and detumescence, the evacuation of pus tissue regeneration promoting can be used for carbuncle, cards such as treating swelling and pain by traumatic injury.
The Radix Paeoniae Alba: claim Radix Paeoniae Alba again, cold nature, liver, spleen two warps are gone in bitter in the mouth, acid.Effect cures mainly: 1, nourishing blood to suppress the hyperactive liver: these article bitter in the mouth, acid, go into Liver Channel, and can tonifying liver blood and easing the affected liver.Be usually used in cards such as menoxenia, dysmenorrhea.2, astringing YIN to stop sweating: these article picric acid, can nourish blood and seek, thus the ability astringing YIN to stop sweating, cards such as spontaneous perspiration commonly used, night sweat, yellowish perspiration.3, pain relieving in slow: these article picric acid, be slightly cold, go into liver spleen two warps, ability nourishing blood to suppress the hyperactive liver and relieving spasm to stop pain.Be usually used in stomachache, hypochondriac pain, have a stomachache, have loose bowels, card such as dysentery.4, suppressing liver-YANG: these article are bitter can nourishing YIN, and acid can restrain, goes into Liver Channel again, and the liver libido evil of loosing is held back, so the ability suppressing liver-YANG is usually used in the card of excessive rising of liver-YANG.
Radix Angelicae Sinensis: warm in nature, acrid in the mouth, sweet; Go into the heart, liver, spleen, lung four warps.Effect cures mainly: 1, nourshing blood and promoting blood circulation: these article sweet in the mouth and weighing, so specially can enrich blood, its gas is light and hot, and again can promoting the circulation of blood, invigorating middle warmer has, in the row benefit is arranged, the sincere gas medicine in the blood, also the panacea in the blood is also.These article are good hematonic, so be applicable to the various syndromes that blood deficiency causes.2, promoting blood circulation and stopping pain: Radix Angelicae Sinensis can pursue congestion, and tissue regeneration promoting blood makes unobstructed vessel and gas parallel, flows round without stopping.Be usually used in traumatic injury stasis of blood pain, carbuncle stasis pain, puerperal the stasis of blood stomachache that stagnates, card such as rheumatic arthralgia and meridians are unfavorable, these article have good promoting blood circulation and stopping pain effect.3, nourishing blood for regulating menstruation.4, loosening bowel to relieve constipation: it is few to be used for blood deficiency Tianjin, the dryness of the intestine constipation.Disease is seen: constipation, and lusterless complexion, severe palpitation is had a dizzy spell.5, sending down the abnormal ascending QI cough-relieving: the hot temperature of Radix Angelicae Sinensis, go into lung meridian, depressed lung-energy dispersing is arranged, the merit of sending down the abnormal ascending QI cough-relieving.6, Radix Angelicae Sinensis should be used for headache due to deficiency of blood and headache due to blood stasis person.
Chinese angelica blood supplementing is invigorated blood circulation, menstruction regulating and pain relieving, loosening bowel to relieve constipation.Be used for blood deficiency and yellow complexion, dizzy cardiopalmus, menoxenia, amenorrhea dysmenorrhea, asthenia cold abdominalgia, dryness of the intestine constipation, rheumatic arthralgia, injury from falling down, ulcer sores.
Venenum Bufonis: warm in nature, sweet in the mouth, suffering, poisonous; Go into stomach, the heart, kidney three warps.Effect cures mainly: 1, removing toxic substances and promoting subsidence of swelling: but the sweet emergency of these article, and Xin Nenghang looses, treating the poisonous disease with poisonous drugs, the merit of the removing toxic substances and promoting subsidence of swelling that tool is stronger, available carbuncle furuncle, the cards such as laryngopharynx swelling and pain controlled.2, pain relieving is had one's ideas straightened out: but the sweet relieving spasm to stop pain of these article, and Xin Wen disperses logical closing, and the double effect of having one's ideas straightened out of good pain relieving is arranged, and can be used for diseases such as acute filthy disease, toothache.
Cornu rhinocerotis: claim Cornu rhinocerotis again, cold in nature, salty in the mouth, hardship; Go into the heart, liver, stomach three warps.Effect cures mainly: heat clearing away arresting convulsion: these article clearing up internal heat by using drugs of bitter in taste and cold in nature, saltyly go into blood system, and the fire of liver stomach three warps of being apt to clear away heart-fire is the special-purpose medicine of Xie Yingfen, noxious heat in the blood system.So epidemic febrile disease caused by exogenous pathogens, intense heat in both QI and blood systems, intenseness of heat wind symptom etc., the merit of using that the heat clearing away arresting convulsion is then arranged.2, removing pathogenic heat from blood and toxic substance from the body: these article are joined the army into blood, and the pyretic toxicity of separating blood system with cold is long, and battalion is cloudy so available treatment heat is burnt, and heat is given birth to forcing blood, hot carbuncle toxin, and heresies such as bloody dysentery are gone into nutrient blood, the card of the absurd row of forcing blood.3, skin ulcer is treated in detoxifcation.
Moschus: warm in nature, acrid in the mouth, go into the heart, spleen, liver three warps.Effect cures mainly: the refreshment of 1, having one's ideas straightened out: the hot perfume (or spice) of these article is walked to scurry, and can go into the heart to have one's ideas straightened out, to exorcise evil spirits to open and close, and coma is returned to normal, and the stronger logical power of closing of having one's ideas straightened out is arranged, and is refreshment analepsia key medicine.Excess syndrome of stroke such as all apoplexy, syncope due to accumulation of phlegm, infantile convulsion, unconsciousness due to high fever, see locked mouth arranged, hold, arteries and veins is strong etc., an all available article are with emergency.2, the collateral dredging of passing through: these article are hot to loose that temperature is logical, fragrance is walked to scurry, and 12 warps that can pass through have the merit of the collateral dredging of passing through, and can be used for the cards such as amenorrhea ， mass in the abdomen due to the blockage of meridian.3, promoting blood circulation and stopping pain: the hot temperature of loosing of these article is logical, both adjustable mechanism of qi the meridian dredging, can stagnating of promoting the circulation of blood branching tie with dissipating blood stasis again, has the merit of blood circulation promoting and dispersing pathogen accumulation, reducing swelling and alleviating pain.To swollen ulcer drug, diseases such as traumatic injury, it is knowingly followed the example of a wrongdoer for significantly, is one of surgery good medicine.4, the tire of hastening parturition down: its fragrant virtue of these article is strong, kindly can walk to scurry and the key of being open to the custom; 12 warps that in addition can pass through again, the merit of tool promoting the circulation of QI to relieve pain, blood circulation promoting and dispersing pathogen accumulation; Render a service so expedite the emergence of down tire, to married woman's difficult labour, cards such as retention of placenta, retention of dead fetus all can be used.5, parasite killing detoxifcation: the warm little hardship of these article suffering, fragrance virtue are strong.Hot fragrant anthelmintic, uninteresting parasite killing so these article are for oral administration, have the power of the Enterozoa of killing; Again because of these article can be open to the custom key, promoting flow of QI and blood, the eliminating stagnation of stimulating the menstrual flow, so the also merit of prodigiosin system parasites poison.
The main effect that Ganoderma spore powder has is following:
1, antitumaous effect:
Ganoderma spore powder has obvious inhibitory action to kinds of tumor cells.Be used to cooperate radiotherapy, the chemotherapy of malignant tumor patient, can strengthen patient's toleration, alleviate side effect, improve hemopoietic function of bone marrow, the transfer of leukocyte increasing, recurrence, the enhance immunity ability promotes rehabilitation.But health invigorating and anti-cancer ability after patient with advanced cancer is taken are alleviated the generation and the development of complication, prolong survival period, improve the quality of living.
2, treatment cardiovascular disease:
Ganoderma spore powder has the effect to the blood pressure two-ways regulation, and it is the diastole coronary artery blood flow effectively, microcirculation improvement; Increase myocardial oxygen delivery, purify the blood, reduce cholesterol and neutral fat content in the blood; Prevent and dissolve the thrombosis in the blood vessel; Blood circulation promoting has protective effect to acute myocardial ischemia, can reduce the formation of atheromatous plaque.For diseases such as coronary heart disease, angina pectoris, arteriosclerosis, hypertension, hyperlipidemia, have prevention and auxiliary treatment effect preferably.
3, treatment digestive system disease:
Ganoderma spore powder has the protecting liver and detoxication function, can promote the metabolism of liver to medicine, poisonous substance, improves the regeneration capacity of liver, effectively improves liver function.Can improve the pancreas blood circulation, improve the pancreas physiological function, blood sugar lowering.The metabolism of ability facilitating digestion system.Diseases such as hepatitis, gastritis, gastric and duodenal ulcers, diabetes, chronic renal failure there is the obvious treatment effect.
4, treatment respiratory system disease:
Ganoderma spore powder has spasmolytic, antiasthmatic effect to the organ smooth muscle, can press down the bones of the body, eliminate the phlegm, and is all effective in cure for chronic bronchitis and bronchial asthma etc.
5, treatment nervous system disease:
Ganoderma spore powder has regulating action to the central nervous system; Stable, calm, analgesic effect is arranged, for the neurasthenia with Yin nervous, the overtired insomnia that causes, dizziness, weak, gastrointestinal dysfunction, forgetful, inappetence, have palpitation, breathe hard, symptom such as hyperhidrosis has the effect of improvement.
6, improve the human immunologic function:
Ganoderma spore powder can improve the function of cellular immunization and two aspects of humoral immunization; Promote leukocyte to increase; Improve the content of immunoglobulin and complement, the generation of inducing interferon, the activity of activation natural killer cell and macrophage; The weight of enhance immunity organ thymus, spleen, liver, thus enhances human body is to the resistivity of various diseases.
7, defying age:
Ganoderma spore powder can be eliminated intravital free radical, the termination lipid peroxidation, and the protection cell, the division algebraically of prolongation passage cell is promoted cell survival, promotes metabolism, health invigorating, thereby effective slow down aging, but take life prolonging for a long time.
Lignum Aquilariae Resinatum: warm in nature, acrid in the mouth, hardship; Go into kidney, spleen, stomach three warps.Effect cures mainly: 1, promoting the circulation of QI to relieve pain: the hot fragrant temperature of these article is logical, temperature and not dry, and row and not letting out, and good promoting the circulation of QI to relieve pain effect is arranged.So with controlling abdominal distention, all cards of traumatic injury are very imitated.2, during sending down the abnormal ascending QI was transferred: this quality resedimentation, the fragrant liter of gas loose.Go into the taste warp, easing stomach-QI rises temper, and is warm in nature and not dry, benefaction and not letting out.During sending down the abnormal ascending QI is transferred, the kind Deficiency and coldness of spleen and stomach of controlling, the imbalance of going up and down, vomiting constipation.3, restoring normal coordination between the heart and kidney: this quality is heavy and fall, and Xin Xiang master's liter had both risen and falls, restoring normal coordination between the heart and kidney, and the extreme misery that both helped is so cure mainly it.4, the kidney warming improving inspiration by invigorating kidney-QI: the sedimentation of these article has the merit that improving inspiration by invigorating kidney-QI is returned unit, the dyspnea and cough due to deficiency of the kidney of controlling commonly used.These article temperature and not dry, row and not letting out reaches kidney and leads fire and return unit, and the merit of sending down the abnormal ascending QI is arranged, and so the evil of no dispelling the stagnated QI is for controlling the good medicine of dyspnea and cough due to deficiency of the kidney.5, the kidney warming is warm smart: this article temperature invigorating kidney-YANG, warm lean liquid.6, tonifying YANG eliminating impediment: the pure sun of these article and rising, body weight and falling, acrid in the mouth is wandered away, and the gas hero is walked crosswise, so exceedingly high ability merit is arranged, replenishing vital QI with drugs of warm nature internal organs, relaxing muscles and tendons and activating QI and blood in the collateral, function tonifying YANG eliminating impediment.
Rhizoma Cyperi: be sedge, the dry root of dried tuber footpath, excavate autumn, sing the hair must, put the boiling water part omitted boil or steam after dry living usefulness, but also processed with vinegar usefulness.This moral character is hot, flat, and mildly bitter flavor, sweet is returned liver, spleen, tri-jiao channel.Effect cures mainly: these article have dispersing the stagnated live-QI to relieve the stagnation of QI, menstruction regulating and pain relieving, the effect in transferring of regulating the flow of vital energy.
Lotus leaf drink: have clearing away summer-heat and eliminating dampness, rise and send out sliding sun, the effect of hemostasis.Use always and control diarrhea due to summer heat and dampness, dizzy, the aqueous vapor edema, thunder-headache is spitted blood, epistaxis, metrorrhagia is had blood in stool, puerperal blood faints.
Herba Solani Nigri: cold in nature, bitter in the mouth, little sweet, slightly poisonous; Go into lung, liver, stomach three warps.Effect cures mainly: 1, heat-clearing and toxic substances removing: these article bitter cold, and the heat clearing away of cold ability, so the eliminating the pathogens from the lung of bitter ability, liver, stomach three warps are can heat-clearing and toxic substances removing.Be usually used in treating cards such as furuncle, carbuncle, erysipelas.2, promoting blood circulation and detumescence: these article bitter cold, go into Liver Channel, then go into blood system, so the ability promoting blood circulation and detumescence is usually used in treating erysipelas, scrofula traumatic injury etc.3, the spasmolytic of reducing phlegm: these article are bitter can drying dampness to eliminate phlegm, cold can heat clearing away.Go into then removing heat from the liver of Liver Channel.Calm down Yin Re and moving liver-wind and spasmolytic.So the merit of the spasmolytic of reducing phlegm is arranged, can be used for children's's ailment said due to cold or exposure, diseases such as heat symptom-complex infantile convulsion.4, liver heat removing and eyesight improving: these article are cold in nature.Go into Liver Channel again, thus can removing heat from the liver and make eye bright, can be used for the liver-fire wind heat and the diseases such as conjunctival congestion and swelling pain pterygium that cause.5, dispelling wind for relieving itching: these article bitter in the mouth, bitter ability dampness removing to stop itchin, these article can be invigorated blood circulation.These article treatment pruritus due to wind pathogen commonly used, scabies is itched bitterly, cards such as day bleb eczema.
Herba Scutellariae Barbatae: property is flat, acrid in the mouth, little hardship; Go into the heart, lung, liver, kidney four warps.Effect cures mainly: 1, heat-clearing and toxic substances removing: these article acrid in the mouth, and little hardship, property is flat.Effect with heat-clearing and toxic substances removing, oral administration, but external.Both can separate insect poison, also can antidote against snake bite, be the good merchantable brand of bactericidal antiphlogistic.Use always and control dysentery, laryngopharynx swelling and pain, innominate toxic swelling, jaundice, throat moth, snakebite, furuncle, lung abscess, card such as carbuncle on the back, 2, hemostasis: this moral character is flat, the little hardship of acrid in the mouth, tool heat clearing away, blood stasis dispelling, the effect of hemostasis.Cards such as using always and control haematemesis, epistaxis, hematuria, have blood in stool.3, eliminating stasis to stop pain: the property that these article acrid in the mouth, hot tool are walked to scurry has and disperses, circulation of qi promoting, promoting the circulation of blood effect.So can be used for the stagnation of QI that a variety of causes causes, expectorant coagulates, diseases such as blood stasis.Scrofula sucutaneous nodule, the cards such as globus hystericus controlled commonly used.4, promoting the circulation of QI to induce diuresis: these article acrid in the mouth, little hardship, the merit of tool promoting the circulation of QI to induce diuresis.Can be used for functional activity of QI being not smooth, the card that stops in the muddy water.Stagnation of QI hypochondriac pain, tympanites, extensive abdominal edema, the cards such as sufficient puffy face controlled commonly used.
JIANZHONGXIAO: abnormal smells from the patient is sour and astringent, and little poison is arranged.Function cures mainly: 1, carbuncle, Canis familiaris L. sting.2, all toxic swellings.
The compatibility mechanism of prescription of the present invention: prescription compatibility of the present invention is rigorous, through sick place.Especially Squama Manis preparata, but dispelling toxicity, detoxicating kill and suppress tumor cell, Yin Yang balancing, enhancing immunity; Venenum Bufonis, Moschus promote Squama Manis preparata kill tumor cell; The Moschus causing resuscitation with aromatic drugs, penetration power is strong, through sick place.Ganoderma spore powder has, and sympotoms caused by cold factors or apoplexy due to deficiency anticancer, that regulate immunity, anti-curing oncoma, anti-leucocytes reduction, raising human body add reality, and its body is not anti-sends an expedition against, thereby notes adopting the agent of tonification or temperature compensation, even send an expedition against.Be prone to also select for use that abnormal smells from the patient is thin, the less medicine of toxicity is treated.
Squama Manis preparata, Venenum Bufonis, Moschus, Ganoderma spore powder, Poria, Rhizoma Cyperi, Lignum Aquilariae Resinatum, Radix Angelicae Sinensis, the Radix Paeoniae Alba, Rhizoma Chuanxiong in the prescription of the present invention, QI invigorating is set upright, and blood circulation promoting and blood stasis dispelling is anticancer, press down cancer, kill cancer cell function.In the side: Squama Manis preparata has powerful strengthening vital QI to eliminate pathogenic factors to body, and the traditional Chinese medical science thinks that the human righteousness contains then heresy and can not invade, and can improve the leukocytic ability of having a liking for that gulps down.Venenum Bufonis kill cancer cell heat-clearing and toxic substances removing, treating the poisonous disease with poisonous drugs, but great mass of data proves Venenum Bufonis, Moschus kill cancer cell.Tumor patient is all deposited yin and yang imbalance in vivo, and vigour is lost empty, the expectorant blood coagulation stasis of blood, and three kinds of basic etiology and pathologies of cancer poison coalescence, three kinds of factors are: void, the stasis of blood, poison.These three kinds of factors are interrelated, in human body, form vicious cycle, finally cause the cancerous cell diffusion transfer, and human life is depleted.The traditional Chinese medical science thinks that the real disease that belongs to asthenia of tumor has concurrently and gathers, and doctor trained in Western medicine thinks that body immunity is a main cause due to descending.The Ganoderma spore powder has stronger raising antibody mediated immunity function function.Japan experiment proof: the anticancer rate of Ganoderma spore powder reaches 80～95%, and multiple malignant tumor such as leukemia, esophageal carcinoma, gastric cancer, intestinal cancer, pulmonary carcinoma, hepatocarcinoma etc. are all had significant curative effect.The Ganoderma spore powder contains the material of a kind of " glucosidase " can strengthen the body antitumaous effect, also contains the derivant of interferon---double stranded RNA, can get into cancerous cell and suppress its propagation.Poria, the Radix Paeoniae Alba, Radix Angelicae Sinensis, Rhizoma Chuanxiong are that SIWU TANG is enriched blood greatly in the side, and blood circulation promoting and blood stasis dispelling it is reported, are that a kind of broad spectrum activity is strangled the cancerous cell medicine, have the cancer effect of obvious inhibition telomerase activation.Lignum Aquilariae Resinatum, Rhizoma Cyperi, the effect of regulating the flow of vital energy, and equilibrium between yin and yang effect in the adjustment body, Cornu rhinocerotis clears away heart-fire through pyretic toxicity.
Complete in a word side has: fill blood regulate yin-yang, blood circulation promoting and blood stasis dispelling, treating the poisonous disease with poisonous drugs, human body immunity improving power, kill cancer cell anticancer value-added functionality.
Positive beneficial effect of the present invention:
1, Chinese medicine composition of the present invention is suitable for the various tumors of treatment, cancer, for example: cerebroma, hepatocarcinoma, esophageal carcinoma, gastric cancer, skin carcinoma or the like.Utilize the various tumors of Drug therapy of the present invention, determined curative effect, convenient inexpensive, safe and reliable is a kind of good medicine of treating tumor.
2, utilize the various tumors of Drug therapy of the present invention, it is evident in efficacy, and total effective rate reaches more than 90%.
Utilize the present invention to treat the medicine of tumor and the clinical data of the various tumors of capsule for treating thereof:
(one), for many years utilizes capsule for treating glioma patient 16 examples of Chinese medicine composition of the present invention and preparation thereof, male 11 examples; Woman's 5 examples, wherein minimal ages is 18 years old, maximum age 82 years old; Operation back 5 examples; Take the capsule example 1 course of treatment 7 that the present invention treats tumor, take the capsule example 2 courses of treatment 9 that the present invention treats tumor, dead 1 example.Wherein cure 5 examples among the 16 routine glioma patients, produce effects 8 examples, invalid 2 examples, dead 1 example, its total effective rate is 81.25%.
The glioma model case:
1, Zhang, woman, people from Xixia County, Nanyang; Morbidity in the time of 8 years old, disease is seen insomnia, headache, repeated cold, at local hospital admission; Doubting is cerebroma, and the back is changeed the Wuhan PLA General Hospital and is diagnosed as congenital cerebral glioma through the expert, needs operative treatment; Expense is higher, because patient's family economic condition is relatively poor, has abandoned operative treatment.After take analgesic for a long time, it is invalid to control for a long time through Chinese and western medicine over surplus in the of ten year.After come here to go to a doctor upon somebody's introduction, according to patient's symptom, the therapeutic scheme of taking is: (instructions of taking is: one after each meal, every day 3 times, each 5, every capsules 0.4g to take the capsule preparations that the present invention treats tumor; 30 days is 1 course of treatment; The capsular raw material of this treatment tumor form see embodiment 2 for details), take 1 course of treatment continuously after, insomnia, headache transference cure; Do cranium CT check, the tumor body disappears basically, and does cranium CT check after taking 1 course of treatment continuously; The tumor complete obiteration, recovery from illness is followed up a case by regular visits to and was not had recurrence in 2 years.
2, Zhao, the man, 62 years old now, the headache phenomenon in April, 2007 appearred in Wu Liqiao people from town, Xixia County, Nanyang, patient, then goes into a coma when serious, spit out white foams, even shock, hospital's hospitalization in Xixia County is done nuclear-magnetism and is diagnosed as glioma.This county hospital and Shanghai large hospital and hospital general, the military region, Wuhan etc. think that all this tumor growth position can't perform the operation, and this patient have to abandon operative treatment.Introduce through the people in February, 2008, comes here to go to a doctor, and according to patient's situation, the therapeutic scheme of taking is: (instructions of taking is: one after each meal, every day 3 times, each 5, every capsules 0.4g to take the capsule preparations that the present invention treats tumor; 30 days is 1 course of treatment; The capsular raw material of this treatment tumor form see embodiment 8 for details), take 1 course of treatment continuously after, headache, tic symptom obviously alleviate; Attack times is less, does the nuclear-magnetism inspection, and tumor is obviously dwindled; Imitate more not square; And check after taking 1 course of treatment continuously, above-mentioned symptom disappears, and follows up a case by regular visits to and does not have recurrence in 1 year.
3, Peng so-and-so, woman, 17 years old, Xi Ping town, Xixia County, Nanyang Tang Jiawan people from village; In March, 1989, the patient begins headache, and the time has nauseatingly, and press cold, fever etc. the medicine does no good in commune hospital, locality town; After be brain CT, doubtful brain has occupying lesion, does nuclear-magnetism again and is diagnosed as cerebroma; With further inspection again, be diagnosed as: cerebral glioma, surgical resection therapy to hospital general, the military region, Wuhan; Operation back headache, feel sick, dizzy, appetite difference symptom all disappears.After June nineteen ninety, this patient was because of flu, occur headache again, feel sick, weak, the time insomnia is arranged, memory subtracts greatly, behind Xixia County's hospital admission; Doing the nuclear-magnetism inspection, think that operation is back more than 1 year, is former cerebral glioma recurrence; Fail to respond to any medical treatment, after to hospital general, the military region, Wuhan (the former hospital that performs an operation) again, look for former doctor to go to a doctor; This doctor says: be the cerebral glioma recurrence after operation, can not perform the operation again, the suggestion expectant treatment.After upon somebody's introduction, come here to go to a doctor, according to conditions of patients, the therapeutic scheme of taking: (instructions of taking is: one after each meal, every day 3 times, each 5, every capsules 0.4g to let the capsule of this patient's trial edition invention treatment tumor; 30 days is 1 course of treatment; The capsular raw material of this treatment tumor form see embodiment 12 for details), take 1 course of treatment continuously after, sx is not vomitted, spirit takes a turn for the better, significant effective; Above-mentioned symptom is eliminated after taking 2 courses of treatment continuously, does the atrophy of CT tumor body and loses, recovery from illness.
(two), for many years utilize capsule for treating patients with uterine myoma 230 examples of Chinese medicine composition of the present invention and preparation thereof, obtain significant curative effect.Wherein minimal ages is 29 years old, maximum age 67 years old.
Criterion of therapeutical effect and therapeutic outcome thereof:
Recovery from illness: take 1 to 3 course of treatment of medicine of the present invention, muscular tumor all disappears.
Produce effects: take 1 to 3 course of treatment of medicine of the present invention, muscular tumor is obviously dwindled.
Invalid: take 1 to 3 course of treatment of medicine of the present invention, muscular tumor is not seen and is dwindled.
This is organized 230 routine patients with uterine myoma and takes medicine of the present invention after 2 courses of treatment, 219 examples of fully recovering, and produce effects 9 examples, invalid 2 examples, total effective rate reaches 99.13%.
This group patients with uterine myoma is taken the present invention and is treated the capsular method of tumor and be: one after each meal, every day 3 times, each 5, every capsules 0.4g; 50 days is 1 course of treatment.
Model case:
1, the king so-and-so, woman, 38 years old, people from Xixia County, Nanyang; Go to a doctor to the People's Hospital, Xixia County in May, 2006, disease is seen: yellowish complexion, become thin, malaise, readme: MBV is big, general 10～15 days; After the People's Hospital, Xixia County B ultrasonic is diagnosed as hysteromyoma 18 * 7cm, the clothes Western medicine is invalid, and the doctor lets operative treatment; The patient also wants to have two babies because of having only a girl, is reluctant operative treatment.After upon somebody's introduction, come here to go to a doctor, according to conditions of patients, the therapeutic scheme of employing is: (instructions of taking is an one after each meal, every day 3 times, each 5, every capsules 0.4g to take the capsule that the present invention treats tumor; 50 days is 1 course of treatment; The capsular raw material of this treatment tumor form see embodiment 20 for details), take the present invention and treat the tumor capsule after 1 course of treatment, make B ultrasonic and show that the tumor body dwindles; And take continuously 1 course of treatment, menstruation is also normal, does B ultrasonic and shows that muscular tumor all disappears; Recovery from illness is followed up a case by regular visits to and was not had recurrence in 2 years.
(three), for many years utilize capsule for treating patients with digestive system neoplasms 196 examples of Chinese medicine composition of the present invention and preparation thereof, obtain significant curative effect.Wherein male patient's 126 examples, women patient's 70 examples, patient age is more than 50 years old.
Criterion of therapeutical effect and therapeutic outcome thereof:
Recovery from illness: take 1 to 3 course of treatment of medicine of the present invention, muscular tumor all disappears.
Produce effects: take 1 to 3 course of treatment of medicine of the present invention, muscular tumor is obviously dwindled.
Invalid: take 1 to 3 course of treatment of medicine of the present invention, muscular tumor is not seen and is dwindled.
This is organized 196 routine patients with digestive system neoplasms and takes medicine of the present invention after 2 courses of treatment, 126 examples of fully recovering, and produce effects 63 examples, invalid 7 examples are cured and are reached 64.28%, and total effective rate reaches 96.42%.
This group patients with digestive system neoplasms is taken the present invention and is treated the capsular method of tumor and be: taking medicine before meal usefulness, every day 3 times, each 5, every capsules 0.4g; 50 days is 1 course of treatment.
Model case:
1, Wang, man, 53 years old now, people from Xixia County, Nanyang; This patient in April, 2003 through the People's Hospital, Xixia County the B ultrasonic nuclear-magnetism make a definite diagnosis chemical examination for mid and late liver cancer, the operation of filling a vacancy is done by 301 military hospitals to Beijing, afterwards first quarter moon firmly; Medical expense is very high, and abdominal distention alleviated at that time, and the food drink also takes a turn for the better.Do not perform an operation the frequent pain in preceding hepatic region, abdominal distention, see greasyly do not want to eat, general weakness.Go to May this year Beijing to perform an operation again, above-mentioned card shape increases the weight of after half a year, and anemia, weak, and body weight drops to 106 jin, yellowish complexion, off color by original 126 jin.Arrive Henan Prov. Tumour Hospital's radiotherapy 25 times the end of the year this year again, each 900 yuan, feeling sick just appears in radiotherapy 10 times, abdominal distention, appetite subtract greatly, and some profits are not wanted to eat yet, and meat is not wanted to see yet, and is as weak as water.Come here to go to a doctor after radiotherapy finishes upon somebody's introduction, according to conditions of patients, the therapeutic scheme of taking: (instructions of taking is: taking medicine before meal usefulness, every day 3 times, each 5, every capsules 0.4g to let this patient's trial edition invent the capsule of treating tumor; 50 days is 1 course of treatment; The capsular raw material of this treatment tumor form see embodiment 4 for details), take 2 courses of treatment continuously after, appetite increases; Whole body energetically, abdominal distention also obviously alleviates, and has taken continuously 2 courses of treatment; Stable disease is liver CT, and the tumor body narrows down to 1.2 * 0.8cm by original 10 * 9cm; And taken 1 course of treatment, to do B ultrasonic tumor body and eliminate, chemical examination liver function test index is all normal.
2, the king so-and-so, man, 62 years old now; Yan Zhen people from village, township, stone boundary river, Xixia County, Nanyang, in March, 2007 here prescription on individual diagnosis, it is surplus February that sense is blocked in this patient's feed at that time; Often weak, appetite is poor, yellowish complexion, become thin, the esophageal barium meal perspective is done by institute of traditional Chinese medicine in Xixia County, doubts the esophagus occupying lesion; After make gastroscope again and do pathologic finding after, be diagnosed as hypomere cancer in the esophagus.According to conditions of patients, the therapeutic scheme of taking is: (instructions of taking is: taking medicine before meal usefulness, every day 3 times, each 5, every capsules 0.4g to take the capsule preparations that the present invention treats tumor; 50 days is 1 course of treatment; The capsular raw material of this treatment tumor form see embodiment 14 for details), take 1 course of treatment continuously after, this patient has a meal and no longer blocks, weight increase, spirit takes a favorable turn, and can work recovery from illness.
3, stone so-and-so, man, 72 years old now, carriage return town, Xixia County, Nanyang bulk ground people from village.This patient is diagnosed as the gastric cancer later stage in Qiu Jing Xixia County hospital in 2002, and companion's hepatic metastases.That this patient became thin at that time was weak, promptly tell after the food, anemia is dizzy, moving then asthma, and hospital says that this patient has lost the surgical engine meeting, can only do the chemotherapy and radiation expectant treatment, is in a bad way, and is critically ill.After come here to go to a doctor upon somebody's introduction, according to conditions of patients, the therapeutic scheme of taking is: (instructions of taking is: taking medicine before meal usefulness, every day 3 times, each 5, every capsules 0.4g to take the capsule preparations that the present invention treats tumor; 50 days is 1 course of treatment; The capsular raw material of this treatment tumor form see embodiment 17 for details), take stable disease after 2 courses of treatment continuously, have a meal and do not tell; Body weight also increases, and anemia also takes a turn for the better, not hematochrome 7 before the clothes; Blood test after two months; Leukocyte is raised to more than 6,000 by original more than 2,000, and hematochrome is raised to 9 by 7, and liver B ultrasonic metastatic tumour has dwindled half the.And take the present invention continuously and treat 2 courses of treatment of tumor capsule preparations, health is good, can eat and can sleep, and is in high spirits, is almost recovered.
4, Wang, the man, 52 years old now, village people, peasant were closed in field, Xixia County, Nanyang.Because of diet self-induction esophagus hypomere the plug of blocking is arranged in May, 2003, hospital makees gastroscope and is diagnosed as carcinoma of gastric cardia (late period) in Xixia County.Because of body constitution is good at ordinary times, family economical condition is better, requires operative treatment, and according to patient's situation, hospital will not perform the operation.After come here to go to a doctor upon somebody's introduction, according to patient's situation, the therapeutic scheme of taking is: (instructions of taking is: one after each meal, every day 3 times, each 5, every capsules 0.4g to take the capsule preparations that the present invention treats tumor; 50 days is 1 course of treatment; The capsular raw material of this treatment tumor form see embodiment 1 for details), take 1 course of treatment continuously after, this patient has a meal not have and blocks sensation, imitates more not square; And after taking 1 course of treatment continuously, patient's subjective symptoms takes a turn for the better, and does gastroscopy; The cardia tumor disappears, and weight increase is followed up a case by regular visits to and do not had recurrence in 1 year.
(four), for many years utilize capsule for treating skin carcinoma patient 38 examples of Chinese medicine composition of the present invention and preparation thereof, obtain significant curative effect, and total effective rate reaches more than 90%.
This group skin carcinoma patient takes the present invention and treats the capsular method of tumor and be: one after each meal, every day 3 times, each 5, every capsules 0.4g; 50 days is 1 course of treatment.
Four, the specific embodiment:
Further specify the present invention below in conjunction with embodiment, but do not limit content of the present invention.
Embodiment 1:
The present invention treats the medicine of tumor, representes with weight portion, and the drug main of said treatment tumor will be by 200 parts of crude drug Squama Manis preparatas, 180 parts in Poria; 80 parts of Rhizoma Chuanxiongs, 100 parts of the Radix Paeoniae Albas, 60 parts of Radix Angelicae Sinensis; 10 parts of Venenum Bufoniss, 3 parts of Cornu rhinocerotis, 3 parts in Moschus; 180 parts of Ganoderma spore powders, 30 parts of Lignum Aquilariae Resinatum, 80 parts of Rhizoma Cyperi and lotus leaf drink are processed for 2000 parts.
The dosage form that the present invention treats the medicine of tumor is a capsule.Its capsular method for preparing is:
A, at first the crude drug proportioning ratio according to above-mentioned medicine for treating tumor thing takes by weighing various crude drug;
B, the crude drug Venenum Bufonis that takes by weighing, Cornu rhinocerotis and Moschus added in the lotus leaf drink carry out mixed grinding, grind and process emulsus, add the crude drug Ganoderma spore powder again and carry out air-dryly, it is for use to obtain air-dry medicine after air-dry;
C, will add entry and decoct except that Venenum Bufonis, Cornu rhinocerotis, Moschus, Ganoderma spore powder and other crude drug the lotus leaf drink mix; Decoct repeatedly three times; Each 7～9h that decocts, the addition of water decocts respectively resulting medicinal liquids mixing for add 3～6 times of the crude drug gross weight with three times when decocting at every turn; Be concentrated into pasty state after the mixing, obtain pasty medicament;
D, step c gained pasty medicament is added in the step b air-dry medicine for use, mix homogeneously, air-dry incapsulates the capsule of the tumor that obtains medical treatment (prepared capsular specification is every 0.4g) after air-dry.
Embodiment 2: basic identical with embodiment 1, difference is:
The present invention treats the medicine of tumor, representes with weight portion, and the drug main of said treatment tumor will be by 220 parts of crude drug Squama Manis preparatas, 210 parts in Poria; 90 parts of Rhizoma Chuanxiongs, 130 parts of the Radix Paeoniae Albas, 90 parts of Radix Angelicae Sinensis; 11 parts of Venenum Bufoniss, 4 parts of Cornu rhinocerotis, 4 parts in Moschus; 200 parts of Ganoderma spore powders, 35 parts of Lignum Aquilariae Resinatum, 100 parts of Rhizoma Cyperi and lotus leaf drink are processed for 2300 parts.
Embodiment 3: basic identical with embodiment 1, difference is:
The present invention treats the medicine of tumor, representes with weight portion, and the drug main of said treatment tumor will be by 250 parts of crude drug Squama Manis preparatas, 250 parts in Poria; 100 parts of Rhizoma Chuanxiongs, 150 parts of the Radix Paeoniae Albas, 120 parts of Radix Angelicae Sinensis; 12 parts of Venenum Bufoniss, 5 parts of Cornu rhinocerotis, 5 parts in Moschus; 220 parts of Ganoderma spore powders, 40 parts of Lignum Aquilariae Resinatum, 120 parts of Rhizoma Cyperi and lotus leaf drink are processed for 2500 parts.
Embodiment 4: basic identical with embodiment 1, difference is:
The present invention treats the medicine of tumor, representes with weight portion, and the drug main of said treatment tumor will be by 210 parts of crude drug Squama Manis preparatas, 230 parts in Poria; 85 parts of Rhizoma Chuanxiongs, 120 parts of the Radix Paeoniae Albas, 70 parts of Radix Angelicae Sinensis; 11 parts of Venenum Bufoniss, 4 parts of Cornu rhinocerotis, 4 parts in Moschus; 190 parts of Ganoderma spore powders, 32 parts of Lignum Aquilariae Resinatum, 110 parts of Rhizoma Cyperi and lotus leaf drink are processed for 2250 parts.
Embodiment 5: basic identical with embodiment 1, difference is:
The present invention treats the medicine of tumor, representes with weight portion, and the drug main of said treatment tumor will be by 240 parts of crude drug Squama Manis preparatas, 190 parts in Poria; 95 parts of Rhizoma Chuanxiongs, 110 parts of the Radix Paeoniae Albas, 100 parts of Radix Angelicae Sinensis; 12 parts of Venenum Bufoniss, 5 parts of Cornu rhinocerotis, 3 parts in Moschus; 210 parts of Ganoderma spore powders, 36 parts of Lignum Aquilariae Resinatum, 90 parts of Rhizoma Cyperi and lotus leaf drink are processed for 2350 parts.
Embodiment 6: basic identical with embodiment 1, difference is:
The present invention treats the medicine of tumor, representes with weight portion, and the drug main of said treatment tumor will be by 230 parts of crude drug Squama Manis preparatas, 200 parts in Poria; 98 parts of Rhizoma Chuanxiongs, 140 parts of the Radix Paeoniae Albas, 110 parts of Radix Angelicae Sinensis; 10 parts of Venenum Bufoniss, 3 parts of Cornu rhinocerotis, 5 parts in Moschus; 200 parts of Ganoderma spore powders, 35 parts of Lignum Aquilariae Resinatum, 100 parts of Rhizoma Cyperi and lotus leaf drink are processed for 2400 parts.
Embodiment 7: basic identical with embodiment 1, difference is:
The present invention treats the medicine of tumor, representes with weight portion, and the drug main of said treatment tumor will be by 200 parts of crude drug Squama Manis preparatas, 180 parts in Poria; 80 parts of Rhizoma Chuanxiongs, 100 parts of the Radix Paeoniae Albas, 60 parts of Radix Angelicae Sinensis, 10 parts of Venenum Bufoniss; 3 parts of Cornu rhinocerotis, 3 parts in Moschus, 180 parts of Ganoderma spore powders, 30 parts of Lignum Aquilariae Resinatum; 80 parts of Rhizoma Cyperi, 60 parts of Herba Solani Nigris, 30 parts of xyloid stem of Flos Helianthi and lotus leaf drink are processed for 2000 parts.
Embodiment 8: basic identical with embodiment 1, difference is:
The present invention treats the medicine of tumor, representes with weight portion, and the drug main of said treatment tumor will be by 220 parts of crude drug Squama Manis preparatas, 210 parts in Poria; 90 parts of Rhizoma Chuanxiongs, 130 parts of the Radix Paeoniae Albas, 90 parts of Radix Angelicae Sinensis, 11 parts of Venenum Bufoniss; 4 parts of Cornu rhinocerotis, 4 parts in Moschus, 200 parts of Ganoderma spore powders, 35 parts of Lignum Aquilariae Resinatum; 100 parts of Rhizoma Cyperi, 80 parts of Herba Solani Nigris, 40 parts of xyloid stem of Flos Helianthi and lotus leaf drink are processed for 2300 parts.
Embodiment 9: basic identical with embodiment 1, difference is:
The present invention treats the medicine of tumor, representes with weight portion, and the drug main of said treatment tumor will be by 250 parts of crude drug Squama Manis preparatas, 250 parts in Poria; 100 parts of Rhizoma Chuanxiongs, 150 parts of the Radix Paeoniae Albas, 120 parts of Radix Angelicae Sinensis, 12 parts of Venenum Bufoniss; 5 parts of Cornu rhinocerotis, 5 parts in Moschus, 220 parts of Ganoderma spore powders, 40 parts of Lignum Aquilariae Resinatum; 120 parts of Rhizoma Cyperi, 100 parts of Herba Solani Nigris, 50 parts of xyloid stem of Flos Helianthi and lotus leaf drink are processed for 2500 parts.
Embodiment 10: basic identical with embodiment 1, difference is:
The present invention treats the medicine of tumor, representes with weight portion, and the drug main of said treatment tumor will be by 210 parts of crude drug Squama Manis preparatas, 230 parts in Poria; 85 parts of Rhizoma Chuanxiongs, 120 parts of the Radix Paeoniae Albas, 70 parts of Radix Angelicae Sinensis, 11 parts of Venenum Bufoniss; 4 parts of Cornu rhinocerotis, 4 parts in Moschus, 190 parts of Ganoderma spore powders, 32 parts of Lignum Aquilariae Resinatum; 110 parts of Rhizoma Cyperi, 70 parts of Herba Solani Nigris, 35 parts of xyloid stem of Flos Helianthi and lotus leaf drink are processed for 2250 parts.
Embodiment 11: basic identical with embodiment 1, difference is:
The present invention treats the medicine of tumor, representes with weight portion, and the drug main of said treatment tumor will be by 240 parts of crude drug Squama Manis preparatas, 190 parts in Poria; 95 parts of Rhizoma Chuanxiongs, 110 parts of the Radix Paeoniae Albas, 100 parts of Radix Angelicae Sinensis, 12 parts of Venenum Bufoniss; 5 parts of Cornu rhinocerotis, 3 parts in Moschus, 210 parts of Ganoderma spore powders, 36 parts of Lignum Aquilariae Resinatum; 90 parts of Rhizoma Cyperi, 90 parts of Herba Solani Nigris, 45 parts of xyloid stem of Flos Helianthi and lotus leaf drink are processed for 2350 parts.
Embodiment 12: basic identical with embodiment 1, difference is:
The present invention treats the medicine of tumor, representes with weight portion, and the drug main of said treatment tumor will be by 230 parts of crude drug Squama Manis preparatas, 200 parts in Poria; 98 parts of Rhizoma Chuanxiongs, 140 parts of the Radix Paeoniae Albas, 110 parts of Radix Angelicae Sinensis, 10 parts of Venenum Bufoniss; 3 parts of Cornu rhinocerotis, 5 parts in Moschus, 200 parts of Ganoderma spore powders; 35 parts of Lignum Aquilariae Resinatum, 80 parts of 100 portions of Herba Solani Nigris of Rhizoma Cyperi, 42 parts of xyloid stem of Flos Helianthi and lotus leaf drink are processed for 2400 parts.
Embodiment 13:
The present invention treats the medicine of tumor, representes with weight portion, and the drug main of said treatment tumor will be by 200 parts of crude drug Squama Manis preparatas, 180 parts in Poria; 80 parts of Rhizoma Chuanxiongs, 100 parts of the Radix Paeoniae Albas, 60 parts of Radix Angelicae Sinensis, 10 parts of Venenum Bufoniss; 3 parts of Cornu rhinocerotis, 3 parts in Moschus, 180 parts of Ganoderma spore powders; 30 parts of Lignum Aquilariae Resinatum, 80 parts of Rhizoma Cyperi, 80 parts of Herba Scutellariae Barbataes and lotus leaf drink are processed for 2000 parts.
Embodiment 14: basic identical with embodiment 1, difference is:
The present invention treats the medicine of tumor, representes with weight portion, and the drug main of said treatment tumor will be by 220 parts of crude drug Squama Manis preparatas, 210 parts in Poria; 90 parts of Rhizoma Chuanxiongs, 130 parts of the Radix Paeoniae Albas, 90 parts of Radix Angelicae Sinensis, 11 parts of Venenum Bufoniss; 4 parts of Cornu rhinocerotis, 4 parts in Moschus, 200 parts of Ganoderma spore powders; 35 parts of Lignum Aquilariae Resinatum, 100 parts of Rhizoma Cyperi, 100 parts of Herba Scutellariae Barbataes and lotus leaf drink are processed for 2300 parts.
Embodiment 15: basic identical with embodiment 1, difference is:
The present invention treats the medicine of tumor, representes with weight portion, and the drug main of said treatment tumor will be by 250 parts of crude drug Squama Manis preparatas, 250 parts in Poria; 100 parts of Rhizoma Chuanxiongs, 150 parts of the Radix Paeoniae Albas, 120 parts of Radix Angelicae Sinensis, 12 parts of Venenum Bufoniss; 5 parts of Cornu rhinocerotis, 5 parts in Moschus, 220 parts of Ganoderma spore powders; 40 parts of Lignum Aquilariae Resinatum, 120 parts of Rhizoma Cyperi, 120 parts of Herba Scutellariae Barbataes and lotus leaf drink are processed for 2500 parts.
Embodiment 16: basic identical with embodiment 1, difference is:
The present invention treats the medicine of tumor, representes with weight portion, and the drug main of said treatment tumor will be by 210 parts of crude drug Squama Manis preparatas, 230 parts in Poria; 85 parts of Rhizoma Chuanxiongs, 120 parts of the Radix Paeoniae Albas, 70 parts of Radix Angelicae Sinensis, 11 parts of Venenum Bufoniss; 4 parts of Cornu rhinocerotis, 4 parts in Moschus, 190 parts of Ganoderma spore powders; 32 parts of Lignum Aquilariae Resinatum, 110 parts of Rhizoma Cyperi, 90 parts of Herba Scutellariae Barbataes and lotus leaf drink are processed for 2250 parts.
Embodiment 17: basic identical with embodiment 1, difference is:
The present invention treats the medicine of tumor, representes with weight portion, and the drug main of said treatment tumor will be by 240 parts of crude drug Squama Manis preparatas, 190 parts in Poria; 95 parts of Rhizoma Chuanxiongs, 110 parts of the Radix Paeoniae Albas, 100 parts of Radix Angelicae Sinensis, 12 parts of Venenum Bufoniss; 5 parts of Cornu rhinocerotis, 3 parts in Moschus, 210 parts of Ganoderma spore powders; 36 parts of Lignum Aquilariae Resinatum, 90 parts of Rhizoma Cyperi, 110 parts of Herba Scutellariae Barbataes and lotus leaf drink are processed for 2350 parts.
Embodiment 18: basic identical with embodiment 1, difference is:
The present invention treats the medicine of tumor, representes with weight portion, and the drug main of said treatment tumor will be by 230 parts of crude drug Squama Manis preparatas, 200 parts in Poria; 98 parts of Rhizoma Chuanxiongs, 140 parts of the Radix Paeoniae Albas, 110 parts of Radix Angelicae Sinensis, 10 parts of Venenum Bufoniss; 3 parts of Cornu rhinocerotis, 5 parts in Moschus, 200 parts of Ganoderma spore powders; 35 parts of Lignum Aquilariae Resinatum, 100 parts of Rhizoma Cyperi, 105 parts of Herba Scutellariae Barbataes and lotus leaf drink are processed for 2400 parts.
Embodiment 19:
The present invention treats the medicine of tumor, representes with weight portion, and the drug main of said treatment tumor will be by 200 parts of crude drug Squama Manis preparatas, 180 parts in Poria; 80 parts of Rhizoma Chuanxiongs, 100 parts of the Radix Paeoniae Albas, 60 parts of Radix Angelicae Sinensis, 10 parts of Venenum Bufoniss; 3 parts of Cornu rhinocerotis, 3 parts in Moschus, 180 parts of Ganoderma spore powders; 30 parts of Lignum Aquilariae Resinatum, 80 parts of Rhizoma Cyperi, 100 parts of JIANZHONGXIAOs and lotus leaf drink are processed for 2000 parts.
Embodiment 20: basic identical with embodiment 1, difference is:
The present invention treats the medicine of tumor, representes with weight portion, and the drug main of said treatment tumor will be by 220 parts of crude drug Squama Manis preparatas, 210 parts in Poria; 90 parts of Rhizoma Chuanxiongs, 130 parts of the Radix Paeoniae Albas, 90 parts of Radix Angelicae Sinensis, 11 parts of Venenum Bufoniss; 4 parts of Cornu rhinocerotis, 4 parts in Moschus, 200 parts of Ganoderma spore powders; 35 parts of Lignum Aquilariae Resinatum, 100 parts of Rhizoma Cyperi, 130 parts of JIANZHONGXIAOs and lotus leaf drink are processed for 2300 parts.
Embodiment 21: basic identical with embodiment 1, difference is:
The present invention treats the medicine of tumor, representes with weight portion, and the drug main of said treatment tumor will be by 250 parts of crude drug Squama Manis preparatas, 250 parts in Poria; 100 parts of Rhizoma Chuanxiongs, 150 parts of the Radix Paeoniae Albas, 120 parts of Radix Angelicae Sinensis, 12 parts of Venenum Bufoniss; 5 parts of Cornu rhinocerotis, 5 parts in Moschus, 220 parts of Ganoderma spore powders; 40 parts of Lignum Aquilariae Resinatum, 120 parts of Rhizoma Cyperi, 150 parts of JIANZHONGXIAOs and lotus leaf drink are processed for 2500 parts.
Embodiment 22: basic identical with embodiment 1, difference is:
The present invention treats the medicine of tumor, representes with weight portion, and the drug main of said treatment tumor will be by 210 parts of crude drug Squama Manis preparatas, 230 parts in Poria; 85 parts of Rhizoma Chuanxiongs, 120 parts of the Radix Paeoniae Albas, 70 parts of Radix Angelicae Sinensis, 11 parts of Venenum Bufoniss; 4 parts of Cornu rhinocerotis, 4 parts in Moschus, 190 parts of Ganoderma spore powders; 32 parts of Lignum Aquilariae Resinatum, 110 parts of Rhizoma Cyperi, 120 parts of JIANZHONGXIAOs and lotus leaf drink are processed for 2250 parts.
Embodiment 23: basic identical with embodiment 1, difference is:
The present invention treats the medicine of tumor, representes with weight portion, and the drug main of said treatment tumor will be by 240 parts of crude drug Squama Manis preparatas, 190 parts in Poria; 95 parts of Rhizoma Chuanxiongs, 110 parts of the Radix Paeoniae Albas, 100 parts of Radix Angelicae Sinensis, 12 parts of Venenum Bufoniss; 5 parts of Cornu rhinocerotis, 3 parts in Moschus, 210 parts of Ganoderma spore powders; 36 parts of Lignum Aquilariae Resinatum, 90 parts of Rhizoma Cyperi, 110 parts of JIANZHONGXIAOs and lotus leaf drink are processed for 2350 parts.
Embodiment 24: basic identical with embodiment 1, difference is:
The present invention treats the medicine of tumor, representes with weight portion, and the drug main of said treatment tumor will be by 230 parts of crude drug Squama Manis preparatas, 200 parts in Poria; 98 parts of Rhizoma Chuanxiongs, 140 parts of the Radix Paeoniae Albas, 110 parts of Radix Angelicae Sinensis, 10 parts of Venenum Bufoniss; 3 parts of Cornu rhinocerotis, 5 parts in Moschus, 200 parts of Ganoderma spore powders; 35 parts of Lignum Aquilariae Resinatum, 100 parts of Rhizoma Cyperi, 140 parts of JIANZHONGXIAOs and lotus leaf drink are processed for 2400 parts.
Embodiment 25:
The present invention treats the medicine of tumor, representes with weight portion, and the drug main of said treatment tumor will be by 200 parts of crude drug Squama Manis preparatas, 180 parts in Poria; 80 parts of Rhizoma Chuanxiongs, 100 parts of the Radix Paeoniae Albas, 60 parts of Radix Angelicae Sinensis, 10 parts of Venenum Bufoniss; 3 parts of Cornu rhinocerotis, 3 parts in Moschus, 180 parts of Ganoderma spore powders; 30 parts of Lignum Aquilariae Resinatum, 80 parts of Rhizoma Cyperi, 3 of animal spleen and lotus leaf drink are processed for 2000 parts.
Embodiment 26: basic identical with embodiment 1, difference is:
The present invention treats the medicine of tumor, representes with weight portion, and the drug main of said treatment tumor will be by 220 parts of crude drug Squama Manis preparatas, 210 parts in Poria; 90 parts of Rhizoma Chuanxiongs, 130 parts of the Radix Paeoniae Albas, 90 parts of Radix Angelicae Sinensis, 11 parts of Venenum Bufoniss; 4 parts of Cornu rhinocerotis, 4 parts in Moschus, 200 parts of Ganoderma spore powders; 35 parts of Lignum Aquilariae Resinatum, 100 parts of Rhizoma Cyperi, 3 of animal spleen and lotus leaf drink are processed for 2300 parts.
Embodiment 27: basic identical with embodiment 1, difference is:
The present invention treats the medicine of tumor, representes with weight portion, and the drug main of said treatment tumor will be by 250 parts of crude drug Squama Manis preparatas, 250 parts in Poria; 100 parts of Rhizoma Chuanxiongs, 150 parts of the Radix Paeoniae Albas, 120 parts of Radix Angelicae Sinensis, 12 parts of Venenum Bufoniss; 5 parts of Cornu rhinocerotis, 5 parts in Moschus, 220 parts of Ganoderma spore powders; 40 parts of Lignum Aquilariae Resinatum, 120 parts of Rhizoma Cyperi, 3 of animal spleen and lotus leaf drink are processed for 2500 parts.
Embodiment 28: basic identical with embodiment 1, difference is:
The present invention treats the medicine of tumor, representes with weight portion, and the drug main of said treatment tumor will be by 210 parts of crude drug Squama Manis preparatas, 230 parts in Poria; 85 parts of Rhizoma Chuanxiongs, 120 parts of the Radix Paeoniae Albas, 70 parts of Radix Angelicae Sinensis, 11 parts of Venenum Bufoniss; 4 parts of Cornu rhinocerotis, 4 parts in Moschus, 190 parts of Ganoderma spore powders; 32 parts of Lignum Aquilariae Resinatum, 110 parts of Rhizoma Cyperi, 3 of animal spleen and lotus leaf drink are processed for 2250 parts.
Embodiment 29: basic identical with embodiment 1, difference is:
The present invention treats the medicine of tumor, representes with weight portion, and the drug main of said treatment tumor will be by 240 parts of crude drug Squama Manis preparatas, 190 parts in Poria; 95 parts of Rhizoma Chuanxiongs, 110 parts of the Radix Paeoniae Albas, 100 parts of Radix Angelicae Sinensis, 12 parts of Venenum Bufoniss; 5 parts of Cornu rhinocerotis, 3 parts in Moschus, 210 parts of Ganoderma spore powders; 36 parts of Lignum Aquilariae Resinatum, 90 parts of Rhizoma Cyperi, 3 of animal spleen and lotus leaf drink are processed for 2350 parts.
Embodiment 30: basic identical with embodiment 1, difference is:
The present invention treats the medicine of tumor, representes with weight portion, and the drug main of said treatment tumor will be by 230 parts of crude drug Squama Manis preparatas, 200 parts in Poria; 98 parts of Rhizoma Chuanxiongs, 140 parts of the Radix Paeoniae Albas, 110 parts of Radix Angelicae Sinensis, 10 parts of Venenum Bufoniss; 3 parts of Cornu rhinocerotis, 5 parts in Moschus, 200 parts of Ganoderma spore powders; 35 parts of Lignum Aquilariae Resinatum, 100 parts of Rhizoma Cyperi, 3 of animal spleen and lotus leaf drink are processed for 2400 parts.
Claims (8)
1. a medicine of treating tumor is characterized in that: represent that with weight portion the drug main of said treatment tumor will be by 200～250 parts of crude drug Squama Manis preparatas, 180～250 parts in Poria; 80～100 parts of Rhizoma Chuanxiongs, 100～150 parts of the Radix Paeoniae Albas, 60～120 parts of Radix Angelicae Sinensis; 10～12 parts of Venenum Bufoniss, 3～5 parts of Cornu rhinocerotis, 3～5 parts in Moschus; 180～220 parts of Ganoderma spore powders, 30～40 parts of Lignum Aquilariae Resinatum, 80～120 parts of Rhizoma Cyperi and lotus leaf drink are processed for 2000～2500 parts.
2. a medicine of treating tumor is characterized in that: represent that with weight portion the drug main of said treatment tumor will be by 200～250 parts of crude drug Squama Manis preparatas, 180～250 parts in Poria; 80～100 parts of Rhizoma Chuanxiongs, 100～150 parts of the Radix Paeoniae Albas, 60～120 parts of Radix Angelicae Sinensis, 10～12 parts of Venenum Bufoniss; 3～5 parts of Cornu rhinocerotis, 3～5 parts in Moschus, 180～220 parts of Ganoderma spore powders, 30～40 parts of Lignum Aquilariae Resinatum; 80～120 parts of Rhizoma Cyperi, 60～100 parts of Herba Solani Nigris, 30～50 parts of xyloid stem of Flos Helianthi and lotus leaf drink are processed for 2000～2500 parts.
3. a medicine of treating tumor is characterized in that: represent that with weight portion the drug main of said treatment tumor will be by 200～250 parts of crude drug Squama Manis preparatas, 180～250 parts in Poria; 80～100 parts of Rhizoma Chuanxiongs, 100～150 parts of the Radix Paeoniae Albas, 60～120 parts of Radix Angelicae Sinensis, 10～12 parts of Venenum Bufoniss; 3～5 parts of Cornu rhinocerotis, 3～5 parts in Moschus, 180～220 parts of Ganoderma spore powders; 30～40 parts of Lignum Aquilariae Resinatum, 80～120 parts of Rhizoma Cyperi, 80～120 parts of Herba Scutellariae Barbataes and lotus leaf drink are processed for 2000～2500 parts.
4. a medicine of treating tumor is characterized in that: represent that with weight portion the drug main of said treatment tumor will be by 200～250 parts of crude drug Squama Manis preparatas, 180～250 parts in Poria; 80～100 parts of Rhizoma Chuanxiongs, 100～150 parts of the Radix Paeoniae Albas, 60～120 parts of Radix Angelicae Sinensis, 10～12 parts of Venenum Bufoniss; 3～5 parts of Cornu rhinocerotis, 3～5 parts in Moschus, 180～220 parts of Ganoderma spore powders; 30～40 parts of Lignum Aquilariae Resinatum, 80～120 parts of Rhizoma Cyperi, 100～150 parts of JIANZHONGXIAOs and lotus leaf drink are processed for 2000～2500 parts.
5. a medicine of treating tumor is characterized in that: represent that with weight portion the drug main of said treatment tumor will be by 200～250 parts of crude drug Squama Manis preparatas, 180～250 parts in Poria; 80～100 parts of Rhizoma Chuanxiongs, 100～150 parts of the Radix Paeoniae Albas, 60～120 parts of Radix Angelicae Sinensis, 10～12 parts of Venenum Bufoniss; 3～5 parts of Cornu rhinocerotis, 3～5 parts in Moschus, 180～220 parts of Ganoderma spore powders; 30～40 parts of Lignum Aquilariae Resinatum, 80～120 parts of Rhizoma Cyperi, 3 of animal spleen and lotus leaf drink are processed for 2000～2500 parts.
6. according to the medicine of each described treatment tumor of claim 1～5, it is characterized in that: the dosage form of the medicine of said treatment tumor is a capsule.
7. the medicine of treatment tumor according to claim 6 is characterized in that, said capsular method for preparing is:
A, at first the crude drug proportioning ratio according to each described medicine for treating tumor thing of claim 1～5 takes by weighing various crude drug;
B, the crude drug Venenum Bufonis that takes by weighing, Cornu rhinocerotis and Moschus added in the lotus leaf drink carry out mixed grinding, grind and process emulsus, add the crude drug Ganoderma spore powder again and carry out air-dryly, it is for use to obtain air-dry medicine after air-dry;
C, will add entry and decoct except that Venenum Bufonis, Cornu rhinocerotis, Moschus, Ganoderma spore powder and other crude drug the lotus leaf drink mix; Decoct repeatedly three times; Each 7～9h that decocts, the addition of water decocts respectively resulting medicinal liquids mixing for add 3～6 times of the crude drug gross weight with three times when decocting at every turn; Be concentrated into pasty state after the mixing, obtain pasty medicament;
D, step c gained pasty medicament is added in the step b air-dry medicine for use, mix homogeneously, air-dry incapsulates the capsule of the tumor that obtains medical treatment after air-dry.
8. the medicine of treatment tumor according to claim 7 is characterized in that: capsular specification described in the steps d is every 0.4g.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012100123303A CN102552619B (en) | 2012-01-16 | 2012-01-16 | Medicine for treating tumor and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012100123303A CN102552619B (en) | 2012-01-16 | 2012-01-16 | Medicine for treating tumor and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102552619A true CN102552619A (en) | 2012-07-11 |
| CN102552619B CN102552619B (en) | 2013-12-18 |
Family
ID=46400073
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2012100123303A Expired - Fee Related CN102552619B (en) | 2012-01-16 | 2012-01-16 | Medicine for treating tumor and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102552619B (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115192662A (en) * | 2022-03-25 | 2022-10-18 | 骆效黎 | Traditional Chinese medicine composition and medicine for treating tumors |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101172133A (en) * | 2007-10-17 | 2008-05-07 | 崔红彬 | Novel-generation tonic anticancer composite medicine |
| CN101664486A (en) * | 2008-09-05 | 2010-03-10 | 李世芳 | Chinese medicinal preparation for treating tumors |
| CN101869688A (en) * | 2010-06-11 | 2010-10-27 | 中山海济中药研发有限公司 | Chinese medicinal compound preparation for treating uterine myoma |
-
2012
- 2012-01-16 CN CN2012100123303A patent/CN102552619B/en not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101172133A (en) * | 2007-10-17 | 2008-05-07 | 崔红彬 | Novel-generation tonic anticancer composite medicine |
| CN101664486A (en) * | 2008-09-05 | 2010-03-10 | 李世芳 | Chinese medicinal preparation for treating tumors |
| CN101869688A (en) * | 2010-06-11 | 2010-10-27 | 中山海济中药研发有限公司 | Chinese medicinal compound preparation for treating uterine myoma |
Non-Patent Citations (1)
| Title |
|---|
| 蔡玉华等: "子宫肌瘤的中医药治疗及研究现状", 《中国中医药信息杂志》, vol. 6, no. 10, 31 December 1999 (1999-12-31), pages 19 - 22 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115192662A (en) * | 2022-03-25 | 2022-10-18 | 骆效黎 | Traditional Chinese medicine composition and medicine for treating tumors |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102552619B (en) | 2013-12-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101549069A (en) | Application and production method of anti-lymphoma medicine | |
| CN104740546A (en) | Traditional Chinese medicine composition for treating gastric cancer | |
| CN101926882A (en) | Medicinal composition for treating cancer and preparation methods thereof | |
| CN105687409A (en) | Stone needle mud moxibustion and method for preparing same | |
| CN104069162A (en) | Traditional Chinese medicine for treating gouty arthritis and various bone and arthrosis pains | |
| CN103656461A (en) | Traditional Chinese medicinal honeyed pill for treating gastric cancer and preparation method thereof | |
| CN102552619B (en) | Medicine for treating tumor and preparation method thereof | |
| CN103212020A (en) | Traditional Chinese medicine composition for treating functional dyspepsia | |
| CN102861292B (en) | Medicament for treating esophageal cancer and preparation method thereof | |
| CN102846794B (en) | Medicine composition for treating cancer and preparation method thereof | |
| CN105233208A (en) | Traditional Chinese medicine preparation for treating heart failure | |
| CN105435190A (en) | Traditional Chinese medicine composition for treating cold-heat jumble asthma and preparation method of traditional Chinese medicine composition | |
| CN101822808A (en) | External medicine for treating tumor by carrying out hot compress of Chinese herbal medicine | |
| CN102949679A (en) | Medicine for curing lung cancer and preparation method thereof | |
| CN103520644B (en) | Traditional Chinese medicine composition used for treating phlegm stagnation type hyperlipidaemia and preparation method of composition | |
| CN114533831B (en) | Traditional Chinese medicine composition with effects of warming middle-jiao, dispelling cold, eliminating dampness, promoting blood circulation, removing obstruction in channels and relieving pain and heat-covered bag thereof | |
| CN103127398B (en) | Chinese medicament for treating cancers and preparation method thereof | |
| CN103908579A (en) | Spleen and stomach tonifying preparation for resisting side effects of chemotherapy and preparation method thereof | |
| CN105250564A (en) | Traditional Chinese medicine ointment for treating tumors | |
| CN102416059B (en) | Medicinal composition for treating colon cancer | |
| CN104784608B (en) | Improve the preparation method of the medicine of toxicity after chemotherapy of tumors | |
| CN104800724B (en) | Improve the medicine of toxicity after chemotherapy of tumors | |
| CN104383245A (en) | Traditional Chinese medicine mixture for treating yin deficiency and yang excess type insomnia | |
| CN104474440A (en) | Pharmaceutical composition for treatment of nutritional anemia of piglets and preparation method thereof | |
| CN104707003B (en) | The Chinese medicinal capsule for the treatment of hypertension, hyperlipidemia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20131218 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |